Veracyte Inc (VCYT) returns
Veracyte returns over 10 years
$1,000 invested in Veracyte ten years ago was worth $6,641 at the close on October 30, 2026, with dividends reinvested: an average return of 20.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +8.6% | — | $1,086 | -0.9% |
| 3 months | -16.3% | — | $836.57 | +2.1% |
| Year to date | +18.8% | — | $1,188 | +11.7% |
| 1 year | +41.6% | — | $1,416 | +12.4% |
| 3 years | +147.3% | +35.2% | $2,473 | +88.5% |
| 5 years | +4.4% | +0.9% | $1,044 | +76.0% |
| 10 years | +564.1% | +20.8% | $6,641 | +316.6% |
Veracyte return by calendar year
| Year | VCYT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +18.8% | +11.7% | +7.1% |
| 2025 | +6.3% | +17.7% | -11.4% |
| 2024 | +43.9% | +24.9% | +19.1% |
| 2023 | +15.9% | +26.2% | -10.3% |
| 2022 | -42.4% | -18.2% | -24.2% |
| 2021 | -15.8% | +28.7% | -44.6% |
| 2020 | +75.3% | +18.4% | +56.9% |
| 2019 | +121.9% | +31.2% | +90.7% |
| 2018 | +92.6% | -4.6% | +97.2% |
| 2017 | -15.6% | +21.7% | -37.3% |
| 2016 | +7.5% | +12.0% | -4.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: VCYT financials · VCYT valuation
No forecast, no recommendation. This page describes Veracyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.